Harry Finch
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Harry Finch
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Artios Pharma Ltd.
 Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom.
19
| Holding Company | Pharmaceuticals: Major | 19 |
| Public Company | Pharmaceuticals: Major | 12 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Harry Finch
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Comptroller/Controller/Auditor Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chief Executive Officer Founder | |
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Investment Managers | Private Equity Investor Private Equity Investor | |
Lehman Brothers Holdings Plc
 Lehman Brothers Holdings Plc Investment Banks/BrokersFinance Lehman Brothers Holdings Plc provides finance and treasury management services. The company is headquartered in London, UK. | Investment Banks/Brokers | Corporate Officer/Principal | |
Domantis Ltd.
 Domantis Ltd. Pharmaceuticals: MajorHealth Technology Domantis Ltd. develops domain antibody therapeutics for treating highly unmet diseases. It enables DABS to serve as building blocks for therapeutics simultaneously directed at more than one disease target. The company was founded in December 2000 and is headquartered Middlesex, the United Kingdom. | Pharmaceuticals: Major | Founder | |
| ALMIRALL, S.A. | Pharmaceuticals: Major | Director/Board Member | |
Modern Biosciences Ltd.
 Modern Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Part of Istesso Ltd., Modern Biosciences Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in London, UK. The company was founded by Samuel Cameron Williams, Alexander James Stevenson. Samuel Cameron Williams has been the CEO since incorporation. | Pharmaceuticals: Major | Chairman Founder Founder | |
| E-THERAPEUTICS PLC | Biotechnology | Director/Board Member Director/Board Member | |
| POXEL | Pharmaceuticals: Major | Chairman Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
| IP GROUP PLC | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Corporate Officer/Principal | |
| University of Cambridge | College/University | Graduate Degree Doctorate Degree | |
Novavax AB
 Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Pharmaceuticals: Generic | Director/Board Member | |
| University of Leeds | College/University | Doctorate Degree | |
Pharminox Ltd
 Pharminox Ltd Medical/Nursing ServicesHealth Services Pharminox Ltd develops treatments for cancer therapy. The private company is based in Abingdon, UK. The British company was founded by Neil L. Brown. | Medical/Nursing Services | Chairman Director/Board Member | |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Medical Specialties | Corporate Officer/Principal | |
| University of Birmingham | College/University | Doctorate Degree Doctorate Degree | |
| ABLYNX | Biotechnology | Public Communications Contact | |
| University of Stockholm | College/University | Undergraduate Degree | |
| University College London | College/University | Doctorate Degree Doctorate Degree | |
Karus Therapeutics Ltd.
 Karus Therapeutics Ltd. BiotechnologyHealth Technology Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
| AVACTA GROUP PLC | Miscellaneous Commercial Services | President Director/Board Member | |
Vertex Pharmaceuticals (Europe) Ltd.
 Vertex Pharmaceuticals (Europe) Ltd. Medical DistributorsDistribution Services Vertex Pharmaceuticals (Europe) Ltd. operates as a pharmaceutical firm. The company was founded on March 11, 1994 and is headquartered London, the United Kingdom. | Medical Distributors | Director/Board Member | |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member | |
| DIUL GROUP | Pharmaceuticals: Major | Chairman | |
| BICYCLE THERAPEUTICS PLC | Biotechnology | Chairman Director of Finance/CFO | |
Crescendo Biologics Ltd.
 Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
C4X Discovery Ltd.
 C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Director/Board Member Chairman Chief Tech/Sci/R&D Officer | |
Iksuda Therapeutics Ltd.
 Iksuda Therapeutics Ltd. BiotechnologyHealth Technology Iksuda Therapeutics Ltd. operates as a biotechnology company which specializes in the development of next generation biotherapeutics. It creates new generation biological therapeutics through advanced glycosylation and conjugation technologies. The company has core expertise in protein/peptide fictionalization and glycosylation technologies, imparting improved pharmacokinetic properties to a broader range of biological therapeutics. It was founded by David John Simpson and Andrew Watts on November 21, 2007 and is headquartered in Newcastle upon Tyne, the United Kingdom. | Biotechnology | Chairman | |
| Seven Hills Venture Partners Ltd. | Founder | ||
| CIRCIO HOLDING ASA | Biotechnology | Director/Board Member | |
Zogenix International Ltd.
 Zogenix International Ltd. Pharmaceuticals: MajorHealth Technology Zogenix International Ltd. manufactures and markets pharmaceutical products. It develops Brabafen an oral treatment for use in children with Dravet Syndrome or severe myoclonic epilepsy of infancy. The company was founded in 2012 and is headquartered in Maidenhead, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| Schosween 18 Ltd. | Director/Board Member | ||
The Microbiota Co. Ltd.
 The Microbiota Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of 4D Pharma Plc, The Microbiota Co. Ltd. develops a patented bacteria which treats irritable bowel syndrome and related symptoms. The company is based in Manchester, UK. The Microbiota Co. was acquired by 4D Pharma Plc on July 18, 2014 for $1.65 million. | Pharmaceuticals: Major | Director/Board Member | |
| Mbs Director Ltd. | Director/Board Member | ||
| Mbs Secretarial Ltd. | Director/Board Member | ||
Modern Biosciences Nominees Ltd.
 Modern Biosciences Nominees Ltd. Regional BanksFinance Modern Biosciences Nominees Ltd. acts as a nominee, trust, and depository. | Regional Banks | Director/Board Member | |
| Pimco 2664 Ltd. | Director/Board Member | ||
Istesso Ltd.
 Istesso Ltd. BiotechnologyHealth Technology Istesso Ltd. Operates as a drug discovery and development company. The company was founded in 2017 and is headquartered in London, the United Kingdom. | Biotechnology | Chairman | |
Aleta Biotherapeutics, Inc.
 Aleta Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aleta Biotherapeutics, Inc. engages in the immuno-oncology service that focuses on transforming cellular therapeutics. It allows broad spectrum of cancer indication to be targeted including currently intractable solid tumors. The company was founded by Paul Rennert and Roy Lobb and is headquartered in Natick, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| IMMUNOCORE HOLDINGS PLC | Biotechnology | Director/Board Member | |
Upstream Bio, Inc.
 Upstream Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Upstream Bio, Inc. is a clinical-stage biopharmaceutical company based in Waltham, MA, USA. The American company's lead program, upb-101, is a monoclonal antibody that inhibits the TSLP receptor, a validated target that affects various immune cells involved in common and rare diseases. Upstream Bio is leveraging its diverse roots and substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones. The company was founded by Eran Perry and Earn Perry, and Samantha Truex has been the CEO since 2021. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer |
Statistik
International
| Vereinigtes Königreich | 37 |
| Vereinigte Staaten | 8 |
| Schweden | 4 |
| Spanien | 2 |
| Frankreich | 2 |
Sektoral
| Health Technology | 26 |
| Consumer Services | 8 |
| Commercial Services | 7 |
| Finance | 5 |
| Process Industries | 2 |
Operativ
| Director/Board Member | 252 |
| Corporate Officer/Principal | 70 |
| Chairman | 40 |
| Chief Executive Officer | 32 |
| Director of Finance/CFO | 28 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Raphaël Wisniewski | 45 |
| Pierre Legault | 45 |
| Barbara Dalton | 35 |
| Chen-Ming Yu | 33 |
| René Kuijten | 30 |
| Samuel Cameron Williams | 27 |
| Clive Dix | 24 |
| Michael Carter | 22 |
| Mario Polywka | 21 |
| Alexander Stevenson | 19 |
| Jonathan Leslie Tobin | 19 |
| Piers John Morgan | 18 |
| Eva-Lotta Allan | 17 |
| Hamish Alan Cameron | 14 |
| Nora Brennan | 13 |
- Börse
- Insiders
- Harry Finch
- Unternehmensverbindungen
